News
Katie Price has opened up about her growing fears for her son Harvey's health, revealing that the 22-year-old's weight has ...
Katie Price has opened up about her fears for her eldest son Harvey, who she shares with ex boyfriend Dwight Yorke, as his ...
Katie Price has been updating fans on her son Harvey's health journey as he attempts to lose weight. She has explained she ...
The next generation of groundbreaking weight loss drugs used by millions is just over the horizon - and they won't require ...
KATIE Price has revealed her heartbreak after learning that son Harvey’s weight has now crept up to nearly 30 stone. The ...
Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...
Eli Lilly's Mounjaro (Tirzepatide), a dual GIP and GLP-1 receptor agonist, has launched in India, generating buzz as a weight ...
A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.
A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...
Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes were for GLP-1 receptor agonists, such as semaglutide or tirzepatide. New ...
Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results